NewDays has closed a $16 million seed round led by Madrona and General Catalyst to expand its AI-driven telehealth platform for dementia care.
NewDays platform and services
NewDays, a Seattle-based startup, combines live clinical sessions with an AI companion called Sunny to deliver cognitive therapy for people with mild dementia and cognitive impairment. The company offers a generative AI-powered platform that facilitates conversational memory exercises and cognitive games intended to improve quality of life and cognitive health through accessible, scalable telehealth interventions.
Funding and plans
The seed round, announced with a funding date of September 2, 2026, raised $16M and was led by Madrona and General Catalyst. NewDays says it will use the capital to scale its service — which has recently expanded to Nevada — and to continue validating its platform through clinical trials and research aimed at preserving cognitive function. The company was founded in Seattle and is led by CEO and co-founder Babak Parviz alongside co-founder Daniel Kelly. Company website: https://newdays.ai. Software category: HealthTech.
